Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

A new COVID-19 vaccine has been approved, but it's not available to everyone. Aerial drone footage shows the humpback whale (Megaptera novaeangliae) missing its iconic lobed fluke, which is ...

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...